260 related articles for article (PubMed ID: 31482451)
1. The Isolation and Analysis of Circulating Tumor Cells.
Guo T; Stankiewicz E; Mao X; Lu YJ
Methods Mol Biol; 2019; 2054():115-128. PubMed ID: 31482451
[TBL] [Abstract][Full Text] [Related]
2. Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System.
Xu L; Mao X; Imrali A; Syed F; Mutsvangwa K; Berney D; Cathcart P; Hines J; Shamash J; Lu YJ
PLoS One; 2015; 10(9):e0138032. PubMed ID: 26397728
[TBL] [Abstract][Full Text] [Related]
3. Filter-Adapted Fluorescent In Situ Hybridization (FA-FISH) for Filtration-Enriched Circulating Tumor Cells.
Oulhen M; Pailler E; Faugeroux V; Farace F
Methods Mol Biol; 2017; 1634():133-141. PubMed ID: 28819846
[TBL] [Abstract][Full Text] [Related]
4. Microfluidic Separation of Circulating Tumor Cells Based on Size and Deformability.
Park ES; Duffy SP; Ma H
Methods Mol Biol; 2017; 1634():21-32. PubMed ID: 28819838
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a marker independent isolation method for circulating tumor cells in esophageal adenocarcinoma.
Philippron A; Depypere L; Oeyen S; De Laere B; Vandeputte C; Nafteux P; De Preter K; Pattyn P
PLoS One; 2021; 16(5):e0251052. PubMed ID: 33961658
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application.
Chen F; Wang S; Fang Y; Zheng L; Zhi X; Cheng B; Chen Y; Zhang C; Shi D; Song H; Cai C; Zhou P; Xiong B
Oncotarget; 2017 Jan; 8(2):3029-3041. PubMed ID: 27935872
[TBL] [Abstract][Full Text] [Related]
7. Circulating tumor cells: a multifunctional biomarker.
Yap TA; Lorente D; Omlin A; Olmos D; de Bono JS
Clin Cancer Res; 2014 May; 20(10):2553-68. PubMed ID: 24831278
[TBL] [Abstract][Full Text] [Related]
8. Detection of Circulating Tumor Cells (CTCs) in Patients with Testicular Germ Cell Tumors.
Nastały P; Honecker F; Pantel K; Riethdorf S
Methods Mol Biol; 2021; 2195():245-261. PubMed ID: 32852768
[TBL] [Abstract][Full Text] [Related]
9. [Detection and clinical significance of circulating tumor cells in osteosarcoma using immunofluorescence combined with in situ hybridization].
Zhang HQ; Li MH; Wang Z; Lan PH; Lu YJ; Chen GJ; Wang L
Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):485-489. PubMed ID: 28728292
[No Abstract] [Full Text] [Related]
10. Detection and Enumeration of Circulating Tumor Cells with Invasive Phenotype.
Wang H; Wu X
Adv Exp Med Biol; 2017; 994():133-141. PubMed ID: 28560672
[TBL] [Abstract][Full Text] [Related]
11. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
[TBL] [Abstract][Full Text] [Related]
12. A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation.
Frithiof H; Welinder C; Larsson AM; Rydén L; Aaltonen K
J Transl Med; 2015 Apr; 13():126. PubMed ID: 25896421
[TBL] [Abstract][Full Text] [Related]
13. Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance.
Sun YF; Yang XR; Zhou J; Qiu SJ; Fan J; Xu Y
J Cancer Res Clin Oncol; 2011 Aug; 137(8):1151-73. PubMed ID: 21681690
[TBL] [Abstract][Full Text] [Related]
14. Microsieve lab-chip device for rapid enumeration and fluorescence in situ hybridization of circulating tumor cells.
Lim LS; Hu M; Huang MC; Cheong WC; Gan AT; Looi XL; Leong SM; Koay ES; Li MH
Lab Chip; 2012 Nov; 12(21):4388-96. PubMed ID: 22930096
[TBL] [Abstract][Full Text] [Related]
15. Improvement of specific detection of circulating tumor cells using combined CD45 staining and fluorescence in situ hybridization.
Ning N; Zhan T; Zhang Y; Chen Q; Feng F; Yang Z; Liu Z; Xu D; Wang F; Guo Y; Xing J; Guan Y; Cui W
Clin Chim Acta; 2014 Jun; 433():69-75. PubMed ID: 24607330
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of detecting circulating tumor cells in colorectal cancer using subtraction enrichment and immunostaining-fluorescence in situ hybridization (SE-iFISH).
Wu W; Zhang Z; Gao XH; Shen Z; Jing Y; Lu H; Li H; Yang X; Cui X; Li Y; Lou Z; Liu P; Zhang C; Zhang W
Oncotarget; 2017 Mar; 8(13):21639-21649. PubMed ID: 28423493
[TBL] [Abstract][Full Text] [Related]
17. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
[TBL] [Abstract][Full Text] [Related]
18. The Novel Association of Circulating Tumor Cells and Circulating Megakaryocytes with Prostate Cancer Prognosis.
Xu L; Mao X; Guo T; Chan PY; Shaw G; Hines J; Stankiewicz E; Wang Y; Oliver RTD; Ahmad AS; Berney D; Shamash J; Lu YJ
Clin Cancer Res; 2017 Sep; 23(17):5112-5122. PubMed ID: 28615267
[No Abstract] [Full Text] [Related]
19. Circulating tumor cells as "liquid biopsies" to understand cancer metastasis.
Woo D; Yu M
Transl Res; 2018 Nov; 201():128-135. PubMed ID: 30075099
[TBL] [Abstract][Full Text] [Related]
20. Technologies for circulating tumor cell separation from whole blood.
Bankó P; Lee SY; Nagygyörgy V; Zrínyi M; Chae CH; Cho DH; Telekes A
J Hematol Oncol; 2019 May; 12(1):48. PubMed ID: 31088479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]